Zhu, Yasheng
128  Ergebnisse:
Personensuche X
?
1

Design, Synthesis, and Biological Evaluation of Novel EGFR ..:

Zhu, Yasheng ; Ye, Xiuquan ; Wu, Yuxing...
Journal of Medicinal Chemistry.  67 (2024)  9 - p. 7283-7300 , 2024
 
?
2

Discovery of potent and selective c-Met inhibitors for MET-..:

Min, Wenjian ; Wang, Yanyin ; Shen, Hongtao...
European Journal of Medicinal Chemistry.  264 (2024)  - p. 116025 , 2024
 
?
 
?
4

Discovery of Novel Fourth-Generation EGFR Inhibitors to Ove..:

Zhu, Yasheng ; Ye, Xiuquan ; Shen, Hao...
Journal of Medicinal Chemistry.  66 (2023)  21 - p. 14633-14652 , 2023
 
?
6

Discovery of Potent and Wild-Type-Sparing Fourth-Generation..:

Dong, Haojie ; Ye, Xiuquan ; Zhu, Yasheng...
Journal of Medicinal Chemistry.  66 (2023)  10 - p. 6849-6868 , 2023
 
?
7

Cell-free DNA in the management of prostate cancer: Current..:

He, Wei ; Xiao, Yutian ; Yan, Shi..
Asian Journal of Urology.  10 (2023)  3 - p. 298-316 , 2023
 
?
9

ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination ..:

Fan, Yizeng ; Hou, Tao ; Dan, Weichao...
Cell Death & Differentiation.  29 (2022)  8 - p. 1611-1624 , 2022
 
?
11

Discovery of Novel Phosphoinositide-3-Kinase α Inhibitors w..:

Hou, Yi ; Zhang, Fang ; Min, Wenjian...
Journal of Medicinal Chemistry.  65 (2022)  14 - p. 9873-9892 , 2022
 
?
12

Discovery of novel and orally bioavailable CDK 4/6 inhibito..:

Yuan, Kai ; Kuang, Wenbin ; Chen, Weijiao...
European Journal of Medicinal Chemistry.  228 (2022)  - p. 114024 , 2022
 
?
13

Development and clinical advancement of small molecules for..:

Li, Jiaxing ; Wang, Xiao ; Ding, Jiayu...
Acta Pharmaceutica Sinica B.  12 (2022)  6 - p. 2808-2831 , 2022
 
1-15